Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Knowles Corp CEO Sells 200,000 Shares Over Three Days

Jeffrey Niew, President and CEO of Knowles Corp (NYSE:KN), filed a Form 4 on August 14, 2026, disclosing the sale of 200,000 shares of common stock across three trading days between August 12 and August 14, 2026.

Aditi Sarkar | 14 August 2026

Park Ohio CFO Sells 12,000 Shares in August 2026

Patrick W. Fogarty, Vice President and CFO of Park Ohio Holdings Corp, filed a Form 4 on August 14, 2026, disclosing the sale of 12,000 shares of common stock on August 12, 2026, across eight separate transactions at prices ranging from $48.00 to $48.62 …

Anjali Anand | 14 August 2026

Shoals Technologies CEO Brandon Moss Files Form 4

Brandon Moss, Chief Executive Officer and Director of Shoals Technologies Group, Inc. (NASDAQ:SHLS), filed a Form 4 on August 14, 2026, disclosing a tax-withholding transaction in Class A Common Stock dated August 13, 2026.

Aakashdeep | 14 August 2026

Tempus AI Officer Reports Share Transfer in August 2026

Ryan Fukushima, an officer at Tempus AI, Inc. (NASDAQ:TEM), filed a Statement of Changes in Beneficial Ownership on August 14, 2026, disclosing a transaction in Class A Common Stock dated August 12, 2026.

Anjali Anand | 14 August 2026

Aeva Technologies Director Sells 2,500 Shares of Common Stock

A statement of changes in beneficial ownership filed on August 14, 2026 reports that Katherine Motlagh, a director of Aeva Technologies, Inc., sold 2,500 shares of common stock on August 12, 2026.

Anjali Anand | 14 August 2026

Incyte Corp Executive Sells 10,803 Shares in August 2026

A Form 4 filed with the SEC on August 14, 2026, discloses that Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp (NASDAQ:INCY), disposed of 10,803 shares of common stock on August 12, 2026, pursuant to a Rule 10b5-1 trading plan.

Shwetambri Chauhan | 14 August 2026

Twist Bioscience CEO Sells 19,952 Shares Under 10b5-1 Plan

Emily M. Leproust, Chief Executive Officer and Director of Twist Bioscience Corp (NASDAQ:TWST), filed a Form 4 on August 14, 2026, reporting a stock option exercise and subsequent sale of common shares on August 12, 2026, conducted under a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 14 August 2026

Tilman Fertitta Sells Call Options on Wynn Resorts Stock

Tilman J. Fertitta, a director and 10% owner of Wynn Resorts Ltd (NASDAQ:WYNN), filed a Form 4 on August 14, 2026, disclosing the sale of three blocks of call option contracts on Wynn Resorts common stock, all transacted on August 12, 2026.

Aditi Sarkar | 14 August 2026

Twist Bioscience Director Sells 2,240 Shares in Tax Withholding Transaction

A Form 4 filed on August 14, 2026 discloses that Katryn Blake, a director of Twist Bioscience Corp (NASDAQ:TWST), sold 2,240 shares of common stock on August 12, 2026 to cover tax liability associated with the vesting of Restricted Stock Units.

Aditi Sarkar | 14 August 2026

PROCEPT BioRobotics CFO Receives RSUs and Stock Options

Kevin Waters, Executive Vice President and CFO of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on August 14, 2026, disclosing the acquisition of restricted stock units and a stock option grant dated August 13, 2026.

Anjali Anand | 14 August 2026
Support

Hi! How can we help you today?

Loading…